Wednesday · October 7, 2026
Emerging

This Cheap Fiber Supplement Eased Knee Arthritis Pain in Just 6 Weeks

A 117-person randomized trial found that 20 grams of daily inulin fiber measurably eased knee osteoarthritis pain in just six weeks, alongside early signals in gut butyrate and the hormone GLP-1. The effect was modest and unreplicated, but notably easier for people to stick with than a physiotherapy program.

A daily scoop of a fiber called inulin, the kind already sold in supplement aisles as a "prebiotic," measurably eased knee osteoarthritis pain in a new randomized controlled trial out of the University of Nottingham. Over six weeks, people who took 20 grams of inulin a day reported significantly less pain than those on a placebo, and blood tests showed the fiber was doing something placebo could not: raising a gut-derived compound called butyrate and a hormone called GLP-1. For a disease with few good drug options and a huge population of sufferers, a cheap dietary fix that people can actually tolerate is worth taking seriously, even on the strength of one trial.

Daily Inulin Fiber Eased Knee Pain in Nottingham RCT

The trial, published in Nutrients as "Effect of Prebiotic Supplementation With and Without Physiotherapy on Pain and Pain Sensitivity in People with Knee Osteoarthritis", randomized 136 adults with knee osteoarthritis and followed 117 of them through six weeks of treatment. Participants averaged 67.5 years old, were 58.1% female, and started with a baseline pain score of about 4 on a 0-to-10 scale. Compared with a maltodextrin placebo, the group taking 20 grams of inulin daily saw their pain drop by 1.11 points more on that scale, a Cohen's d of 0.57 (p = 0.045). That is a modest effect, but it cleared the threshold researchers consider clinically meaningful. The inulin group also gained grip strength (p = 0.002) and showed improved pressure-pain thresholds (p = 0.009), a lab measure of how sensitized the nervous system has become to pain.

Millions With Knee Osteoarthritis Have Few Good Options

Knee osteoarthritis affects a huge swath of older adults, and the standard toolkit – painkillers, physical therapy, and eventually joint replacement – leaves many people managing chronic pain with side effects or logistical barriers. That is what makes this trial's design useful: it did not test inulin in isolation but against and alongside a digital physiotherapy-supported exercise program (delivered through the Joint Academy platform), which independently reduced pain by 1.55 points versus placebo (d = 0.72, p = 0.002). Combining inulin with the exercise program produced the largest drop, 1.67 points (d = 0.84, p = 0.004), though the researchers found no evidence the two treatments amplified each other beyond simply adding up, and the study was not statistically powered to detect that kind of synergy in the first place.

Inside the 2×2 Trial Design That Isolated Fiber's Effect

What sets this study apart methodologically is its 2×2 factorial structure: four arms – inulin alone, exercise alone, both combined, and placebo – that let researchers cleanly separate the fiber's effect from the exercise program's effect rather than lumping them together. Led by Dr. Afroditi Kouraki and senior author Professor Ana Valdes at the University of Nottingham's NIHR Biomedical Research Centre, the trial ran blood work alongside the pain scores. Only the inulin arm raised circulating levels of butyrate, a short-chain fatty acid gut bacteria produce when they ferment fiber (p = 0.0248), and only inulin raised GLP-1, a hormone tied to metabolism and, increasingly, to pain and muscle signaling (p = 0.011). Higher GLP-1 levels also tracked with the grip-strength gains, hinting at what Valdes described, according to ScienceDaily's coverage of the trial, as "a broader gut-muscle-pain axis that warrants further investigation." Notably, adherence mattered here too: only 3.6% of people in the inulin arms dropped out, versus 21% of those in the exercise-only arms, a gap the authors say was statistically significant.

The Butyrate and GLP-1 Signal Is Still a Hypothesis

The authors themselves are careful not to oversell the biology. They flag that the butyrate and GLP-1 measurements came from blood serum, not directly from the gut, and note serum levels do not necessarily reflect what is happening in the intestine where the fermentation actually occurs. They also describe the GLP-1 findings as "hypothesis-generating," since that analysis was exploratory rather than a pre-specified primary outcome. As News-Medical's writeup of the study notes, the trial excluded people with fibromyalgia or irritable bowel syndrome, so it is unclear whether the pain relief would generalize to those overlapping conditions. And with only 117 completers followed for six weeks, this is a single trial: a real effect worth taking seriously, but not yet a settled one. About a fifth of inulin users reported minor gastrointestinal side effects like bloating or gas, though none dropped out because of it.

What Comes Next for Gut-Targeted Osteoarthritis Treatment

For now, the practical takeaway is narrower than the headlines suggest: a cheap, well-tolerated fiber supplement produced a real but modest pain reduction in six weeks, with a retention rate exercise programs could only envy. Dr. Kouraki put it plainly in the same ScienceDaily piece, calling it "the exciting possibility that a simple dietary change, adding a fiber supplement to your breakfast or yogurt, could meaningfully reduce pain and improve physical function." Whether that holds up in larger, longer trials, and whether the gut-butyrate-GLP-1 pathway is truly driving the effect rather than just riding alongside it, is the next question. No long-term follow-up has been reported yet, so nobody knows if the benefit persists, grows, or fades once the six weeks end. Until an independent group replicates it, this is best read as a promising, low-risk lead rather than a new standard of care.

Evidence rating

EMERGING — 73/100

Caveats:

  • Single RCT, not yet replicated
  • Modest effect size for inulin alone (Cohen's d=0.57)
  • Short 6-week duration, no long-term follow-up reported
  • Butyrate/GLP-1 mechanism is correlational within the trial, not independently proven causal

A single randomized controlled trial found a modest, statistically significant pain reduction from daily inulin fiber over six weeks, with early mechanistic signals (gut butyrate, GLP-1) that have not yet been replicated.

References

  1. (2026). Osteoarthritis: Daily supplement shown to ease knee pain within six weeks – GB News. https://www.gbnews.com/health/osteoarthritis-knee-pain-health
  2. Afroditi Kouraki, Susan Franks, Amrita Vijay, et al. (2026). Effect of Prebiotic Supplementation With and Without Physiotherapy on Pain and Pain Sensitivity in People with Knee Osteoarthritis. Nutrients. https://doi.org/10.3390/nu18050714
  3. A daily fiber supplement reduced knee arthritis pain and improved strength – ScienceDaily. ScienceDaily. https://www.sciencedaily.com/releases/2026/07/260724061448.htm